MFDS internationally recognized in approval and assessment fields of biosimilar

Published: 2017-06-28 14:56:00

Updated: 2017-06-28 14:56:00

The Ministry of Food and Drug Safety(MFDS) announced on the 26^th that Korea has been reappointed as a IPRF Biosimilar Working Group member country at the ‘International Pharmaceutical Regulators Forum and International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use(ICH) Meeting in the First Half of 2017.’

With the reappointment, Korea wa...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.